In a significant move, the Delhi High Court has summoned the government and drug regulatory bodies to address a contempt petition regarding the use of diabetes medications, including Ozempic, as weight loss aids. Authorities have been given a four-week period to respond to these serious allegations. The case is scheduled for a follow-up hearing on May 21.
